Risk assessment in fever and neutropenia in children with cancer: What did we learn?
Esther M. te Poele(University Medical Center Groningen), Eveline S.J.M. de Bont(Hôpital Saint-Michel), Wim J. E. Tissing(University Medical Center Groningen), Willem A. Kamps(Pediatric Oncology Group)
Cited by 39
Related Papers
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2000|599